RecruitingPhase 3NCT01696734

Domperidone in Treating Patients With Gastrointestinal Disorders

Treatment Protocol for the Compassionate Use of Domperidone


Sponsor

M.D. Anderson Cancer Center

Enrollment

200 participants

Start Date

Oct 23, 2012

Study Type

INTERVENTIONAL

Conditions

Summary

This phase III trial studies how well domperidone works in treating patients with gastrointestinal disorders. Domperidone may help control chronic gastrointestinal disorders and their symptoms, such as pain, bloating, and nausea and vomiting, by stimulating contraction of the stomach to increase its ability to empty itself of food.


Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This study provides access to domperidone — a medication that helps the stomach empty properly — for patients with gastrointestinal motility disorders (such as gastroparesis, severe acid reflux, or dyspepsia) who have not responded to standard treatments. You may be eligible if: - You are 16 years of age or older - You have gastroparesis, refractory GERD (persistent heartburn or reflux), or severe dyspepsia - You have failed standard therapies for these conditions - You have adequate blood counts and organ function You may NOT be eligible if: - You have a heart condition including prolonged QTc interval, arrhythmias, heart failure, or ischemic heart disease - You take antiarrhythmic drugs or MAO inhibitors - You have a history of active liver failure - You have significant electrolyte imbalances - You had GI bleeding or obstruction in the past 6 weeks - You have a prolactin-secreting pituitary tumour - You are pregnant or breastfeeding - You are allergic to domperidone Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDomperidone

Given PO

OTHERQuestionnaire Administration

Ancillary studies


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01696734


Related Trials